China Accumulated Other Comprehensive Income from 2010 to 2024

SXTC Stock  USD 1.14  0.01  0.88%   
China SXT's Accumulated Other Comprehensive Income is increasing over the years with very volatile fluctuation. Overall, Accumulated Other Comprehensive Income is projected to go to about -215.8 K this year. Accumulated Other Comprehensive Income is gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized. View All Fundamentals
 
Accumulated Other Comprehensive Income  
First Reported
2017-12-31
Previous Quarter
-197.6 K
Current Value
-1 M
Quarterly Volatility
594.3 K
 
Covid
Check China SXT financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among China SXT's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 4.4 K or Interest Expense of 779 K, as well as many indicators such as Price To Sales Ratio of 1.83, Dividend Yield of 0.0 or PTB Ratio of 0.25. China financial statements analysis is a perfect complement when working with China SXT Valuation or Volatility modules.
  
Check out the analysis of China SXT Correlation against competitors.

Latest China SXT's Accumulated Other Comprehensive Income Growth Pattern

Below is the plot of the Accumulated Other Comprehensive Income of China SXT Pharmaceuticals over the last few years. It is gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized. China SXT's Accumulated Other Comprehensive Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in China SXT's overall financial position and show how it may be relating to other accounts over time.
Accumulated Other Comprehensive Income10 Years Trend
Very volatile
   Accumulated Other Comprehensive Income   
       Timeline  

China Accumulated Other Comprehensive Income Regression Statistics

Arithmetic Mean42,879
Geometric Mean63,906
Coefficient Of Variation817.69
Mean Deviation216,024
Median11,825
Standard Deviation350,619
Sample Variance122.9B
Range1.5M
R-Value0
Mean Square Error132.4B
R-Squared0.000015
Significance0.99
Slope299.58
Total Sum of Squares1.7T

China Accumulated Other Comprehensive Income History

2024-215.8 K
2023-227.2 K
2022-197.6 K
2021956.1 K
2020527.8 K
2019-590.7 K
201850.4 K

About China SXT Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include China SXT income statement, its balance sheet, and the statement of cash flows. China SXT investors use historical funamental indicators, such as China SXT's Accumulated Other Comprehensive Income, to determine how well the company is positioned to perform in the future. Although China SXT investors may use each financial statement separately, they are all related. The changes in China SXT's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on China SXT's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on China SXT Financial Statements. Understanding these patterns can help to make the right decision on long term investment in China SXT. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-227.2 K-215.8 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in China Stock

When determining whether China SXT Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of China SXT's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of China Sxt Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on China Sxt Pharmaceuticals Stock:
Check out the analysis of China SXT Correlation against competitors.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China SXT. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China SXT listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.426
Earnings Share
(26.96)
Revenue Per Share
3.65
Quarterly Revenue Growth
(0.22)
Return On Assets
(0.46)
The market value of China SXT Pharmaceuticals is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China SXT's value that differs from its market value or its book value, called intrinsic value, which is China SXT's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China SXT's market value can be influenced by many factors that don't directly affect China SXT's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China SXT's value and its price as these two are different measures arrived at by different means. Investors typically determine if China SXT is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China SXT's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.